PubMed:20520283
Annnotations
TEST-DiseaseOrPhenotypicFeature
Id | Subject | Object | Predicate | Lexical cue | #label |
---|---|---|---|---|---|
T1 | 119-132 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 |
T2 | 226-239 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 |
T3 | 286-304 | DiseaseOrPhenotypicFeature | denotes | bipolar I disorder | DISEASE |
T4 | 397-410 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 |
T5 | 1500-1523 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal symptoms | DISEASE |
T6 | 1884-1907 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal symptoms | DISEASE |
TEST-ChemicalEntity
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T1 | 23-32 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 |
T3 | 51-62 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 |
T5 | 134-143 | ChemicalEntity | denotes | Asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 |
T7 | 463-472 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 |
T9 | 500-509 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 |
T11 | 536-547 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 |
T13 | 761-770 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 |
T15 | 795-806 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 |
T17 | 950-959 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 |
T19 | 1015-1026 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 |
T21 | 1194-1203 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 |
T23 | 1423-1432 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 |
T25 | 1453-1464 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 |
T27 | 1585-1594 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 |
T29 | 1615-1626 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 |
T31 | 1810-1819 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 |
T33 | 1824-1835 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 |
TEST-OrganismTaxon
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 83-91 | OrganismTaxon | denotes | patients |
T2 | 286-295 | OrganismTaxon | denotes | bipolar I |
T3 | 377-385 | OrganismTaxon | denotes | patients |
T4 | 1700-1708 | OrganismTaxon | denotes | patients |
Test-merged
Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
---|---|---|---|---|---|---|
T6 | 1884-1907 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal symptoms | DISEASE | |
T5 | 1500-1523 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal symptoms | DISEASE | |
T4 | 397-410 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 | |
T3 | 286-304 | DiseaseOrPhenotypicFeature | denotes | bipolar I disorder | DISEASE | |
T2 | 226-239 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 | |
T1 | 119-132 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 | |
T9704 | 1700-1708 | OrganismTaxon | denotes | patients | ||
T40754 | 377-385 | OrganismTaxon | denotes | patients | ||
T99368 | 83-91 | OrganismTaxon | denotes | patients | ||
T29189 | 1056-1061 | GeneOrGeneProduct | denotes | all P | ||
T33 | 1824-1835 | ChemicalEntity | denotes | haloperidol | http://purl.obolibrary.org/obo/CHEBI_5613|D006220 | |
T31 | 1810-1819 | ChemicalEntity | denotes | asenapine | http://purl.obolibrary.org/obo/CHEBI_71253|C522667 | |
T29 | 1615-1626 | ChemicalEntity | denotes | haloperidol | http://purl.obolibrary.org/obo/CHEBI_5613|D006220 | |
T27 | 1585-1594 | ChemicalEntity | denotes | asenapine | http://purl.obolibrary.org/obo/CHEBI_71253|C522667 | |
T25 | 1453-1464 | ChemicalEntity | denotes | haloperidol | http://purl.obolibrary.org/obo/CHEBI_5613|D006220 | |
T23 | 1423-1432 | ChemicalEntity | denotes | asenapine | http://purl.obolibrary.org/obo/CHEBI_71253|C522667 | |
T21 | 1194-1203 | ChemicalEntity | denotes | asenapine | http://purl.obolibrary.org/obo/CHEBI_71253|C522667 | |
T19 | 1015-1026 | ChemicalEntity | denotes | haloperidol | http://purl.obolibrary.org/obo/CHEBI_5613|D006220 | |
T17 | 950-959 | ChemicalEntity | denotes | asenapine | http://purl.obolibrary.org/obo/CHEBI_71253|C522667 | |
T15 | 795-806 | ChemicalEntity | denotes | haloperidol | http://purl.obolibrary.org/obo/CHEBI_5613|D006220 | |
T13 | 761-770 | ChemicalEntity | denotes | asenapine | http://purl.obolibrary.org/obo/CHEBI_71253|C522667 | |
T11 | 536-547 | ChemicalEntity | denotes | haloperidol | http://purl.obolibrary.org/obo/CHEBI_5613|D006220 | |
T9 | 500-509 | ChemicalEntity | denotes | asenapine | http://purl.obolibrary.org/obo/CHEBI_71253|C522667 | |
T7 | 463-472 | ChemicalEntity | denotes | asenapine | http://purl.obolibrary.org/obo/CHEBI_71253|C522667 | |
T3195 | 134-143 | ChemicalEntity | denotes | Asenapine | http://purl.obolibrary.org/obo/CHEBI_71253|C522667 | |
T27170 | 51-62 | ChemicalEntity | denotes | haloperidol | http://purl.obolibrary.org/obo/CHEBI_5613|D006220 | |
T96910 | 23-32 | ChemicalEntity | denotes | asenapine | http://purl.obolibrary.org/obo/CHEBI_71253|C522667 |
Test-GeneOrGeneProduct
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1056-1061 | GeneOrGeneProduct | denotes | all P |
Test-merged-2
Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
---|---|---|---|---|---|---|
T96910 | 23-32 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 | |
T27170 | 51-62 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 | |
T3195 | 134-143 | ChemicalEntity | denotes | Asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 | |
T7 | 463-472 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 | |
T9 | 500-509 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 | |
T11 | 536-547 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 | |
T13 | 761-770 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 | |
T15 | 795-806 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 | |
T17 | 950-959 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 | |
T19 | 1015-1026 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 | |
T21 | 1194-1203 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 | |
T23 | 1423-1432 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 | |
T25 | 1453-1464 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 | |
T27 | 1585-1594 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 | |
T29 | 1615-1626 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 | |
T31 | 1810-1819 | ChemicalEntity | denotes | asenapine | C522667|http://purl.obolibrary.org/obo/CHEBI_71253 | |
T33 | 1824-1835 | ChemicalEntity | denotes | haloperidol | D006220|http://purl.obolibrary.org/obo/CHEBI_5613 | |
T29189 | 1056-1061 | GeneOrGeneProduct | denotes | all P | ||
T99368 | 83-91 | OrganismTaxon | denotes | patients | ||
T82371 | 286-295 | OrganismTaxon | denotes | bipolar I | ||
T40754 | 377-385 | OrganismTaxon | denotes | patients | ||
T9704 | 1700-1708 | OrganismTaxon | denotes | patients | ||
T1 | 119-132 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 | |
T2 | 226-239 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 | |
T3 | 286-304 | DiseaseOrPhenotypicFeature | denotes | bipolar I disorder | DISEASE | |
T4 | 397-410 | DiseaseOrPhenotypicFeature | denotes | schizophrenia | D012559 | |
T5 | 1500-1523 | DiseaseOrPhenotypicFeature | denotes | Extrapyramidal symptoms | DISEASE | |
T6 | 1884-1907 | DiseaseOrPhenotypicFeature | denotes | extrapyramidal symptoms | DISEASE |
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 226-239 | HP_0100753 | denotes | schizophrenia |
T2 | 246-251 | HP_0100754 | denotes | manic |
T3 | 286-304 | HP_0007302 | denotes | bipolar I disorder |
T4 | 353-358 | HP_0000618 | denotes | blind |
T5 | 397-410 | HP_0100753 | denotes | schizophrenia |
T6 | 1500-1523 | HP_0002071 | denotes | Extrapyramidal symptoms |
T7 | 1884-1907 | HP_0002071 | denotes | extrapyramidal symptoms |
Allie
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
SS1_20520283_3_0 | 596-629 | expanded | denotes | last observations carried forward |
SS2_20520283_3_0 | 631-635 | abbr | denotes | LOCF |
SS1_20520283_3_1 | 858-891 | expanded | denotes | mixed model for repeated measures |
SS2_20520283_3_1 | 893-897 | abbr | denotes | MMRM |
SS1_20520283_5_0 | 1357-1371 | expanded | denotes | adverse events |
SS2_20520283_5_0 | 1373-1376 | abbr | denotes | AEs |
AE1_20520283_3_0 | SS1_20520283_3_0 | SS2_20520283_3_0 | abbreviatedTo | last observations carried forward,LOCF |
AE1_20520283_3_1 | SS1_20520283_3_1 | SS2_20520283_3_1 | abbreviatedTo | mixed model for repeated measures,MMRM |
AE1_20520283_5_0 | SS1_20520283_5_0 | SS2_20520283_5_0 | abbreviatedTo | adverse events,AEs |